1.Hemodynamic Follow-Up in Adult Patients with Pulmonary Hypertension Associated with Atrial Septal Defect after Partial Closure.
Jinyoung SONG ; June HUH ; Sang Yun LEE ; I Seok KANG ; Chang Ha LEE ; Cheul LEE ; Ji Hyuk YANG ; Tae Gook JUN
Yonsei Medical Journal 2016;57(2):306-312
PURPOSE: We evaluated the hemodynamic statuses of patients after partial closure of atrial septal defects with fenestration due to pulmonary hypertension. MATERIALS AND METHODS: Seventeen adult patients underwent partial atrial septal defect closure and follow-up cardiac catheterization. We analyzed hemodynamic data and clinical parameters before and after closure. RESULTS: The median age at closure was 29 years old. The baseline Qp/Qs was 1.9+/-0.6. The median interval from the operation to the cardiac catheterization was 27 months. The CT ratio decreased from 0.55+/-0.07 to 0.48+/-0.06 (p<0.05). The mean pulmonary arterial pressure decreased from 50.0+/-11.5 mm Hg to 32.5+/-14.4 mm Hg (p<0.05), and the pulmonary resistance index decreased from 9.2+/-3.6 Wood units*m2 to 6.3+/-3.8 Wood units*m2 (p<0.05). Eleven patients (64.7%) continued to exhibit high pulmonary resistance (over 3.0 Wood units*m2) after closure. These patients had significantly higher pulmonary resistance indices and mean pulmonary arterial pressures based on oxygen testing before the partial closures (p<0.05). However, no significant predictors of post-closure pulmonary hypertension were identified. CONCLUSION: Despite improvement in symptoms and hemodynamics after partial closure of an atrial septal defect, pulmonary hypertension should be monitored carefully.
Adult
;
Aged
;
Cardiac Catheterization/*adverse effects
;
Female
;
Follow-Up Studies
;
Heart Defects, Congenital/epidemiology/*physiopathology/*surgery
;
Heart Septal Defects, Atrial/surgery
;
Hemodynamics/*physiology
;
Humans
;
Hypertension, Pulmonary/diagnosis/epidemiology/*physiopathology
;
Male
;
Middle Aged
;
Oxygen
;
Postoperative Complications/diagnosis/epidemiology/*physiopathology
;
Retrospective Studies
;
Treatment Outcome
;
Young Adult
2.Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity.
Jee Hwan AHN ; Byung Ju KANG ; Sun In HONG ; Jung Su LEE ; Jae Seung LEE ; Yeon Mok OH ; Sang Do LEE
Journal of Korean Medical Science 2014;29(12):1665-1671
We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) > or =10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1+/-0.3 m/s vs. 4.6+/-0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47+/-10 mmHg vs. 63+/-17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.
Adolescent
;
Adult
;
Aged
;
Female
;
Humans
;
Hypertension, Pulmonary/*diagnosis/*mortality/physiopathology
;
Male
;
Middle Aged
;
Prevalence
;
Prognosis
;
Reproducibility of Results
;
Republic of Korea/epidemiology
;
Risk Factors
;
Sensitivity and Specificity
;
Survival Rate
;
Vascular Resistance/*drug effects
;
Vasodilator Agents/*diagnostic use
;
Young Adult
3.Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
Jung Yeon LEE ; Gyu Rak CHON ; Chin Kook RHEE ; Deog Kyeom KIM ; Hyoung Kyu YOON ; Jin Hwa LEE ; Kwang Ha YOO ; Sang Haak LEE ; Sang Yeub LEE ; Tae Eun KIM ; Tae Hyung KIM ; Yong Bum PARK ; Yong Il HWANG ; Young Sam KIM ; Ki Suck JUNG
Journal of Korean Medical Science 2016;31(4):553-560
The Korea Chronic Obstructive Pulmonary Disorders Subgroup Study Team (Korea COPD Subgroup Study team, KOCOSS) is a multicenter observational study that includes 956 patients (mean age 69.9 ± 7.8 years) who were enrolled from 45 tertiary and university-affiliated hospitals from December 2011 to October 2014. The initial evaluation for all patients included pulmonary function tests (PFT), 6-minute walk distance (6MWD), COPD Assessment Test (CAT), modified Medical Research Council (mMRC) dyspnea scale, and the COPD-specific version of St. George's Respiratory Questionnaire (SGRQ-C). Here, we report the comparison of baseline characteristics between patients with early- (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage I and II/groups A and B) and late-stage COPD (GOLD stage III and IV/groups C and D). Among all patients, the mean post-bronchodilator FEV1 was 55.8% ± 16.7% of the predicted value, and most of the patients were in GOLD stage II (520, 56.9%) and group B (399, 42.0%). The number of exacerbations during one year prior to the first visit was significantly lower in patients with early COPD (0.4 vs. 0.9/0.1 vs. 1.2), as were the CAT score (13.9 vs. 18.3/13.5 vs. 18.1), mMRC (1.4 vs. 2.0/1.3 vs.1.9), and SGRQ-C total score (30.4 vs. 42.9/29.1 vs. 42.6) compared to late-stage COPD (all P < 0.001). Common comorbidities among all patients were hypertension (323, 37.7%), diabetes mellitus (139, 14.8%), and depression (207, 23.6%). The data from patients with early COPD will provide important information towards early detection, proper initial management, and design of future studies.
Aged
;
Cohort Studies
;
Comorbidity
;
Depression/epidemiology
;
Diabetes Mellitus/epidemiology
;
Dyspnea/complications
;
Female
;
Forced Expiratory Volume
;
Hospitals, University
;
Humans
;
Hypertension/epidemiology
;
Lung/physiopathology
;
Male
;
Middle Aged
;
Pulmonary Disease, Chronic Obstructive/complications/*diagnosis/physiopathology
;
Quality of Life
;
Republic of Korea
;
Respiratory Function Tests
;
Severity of Illness Index
;
Societies, Medical
;
Surveys and Questionnaires
;
Tertiary Care Centers
;
Walk Test